Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced that the FDA cleared the company to proceed with a Phase 3 clinical trial using the investigational EV drug ExoFlo to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. 

A record number of people – totaling more than 3.6 million – were unable to work due to illness during the week in January that officials gathered data for the benchmark U.S. monthly employment report, which coincided with the peak in infections from COVID-19.

A new study from a team in California examined the differences between the sexes in the long-hauler response to SARS-CoV-2 infection.

The risk of illness from Covid-19 dropped 95.8% among people who received both shots of Pfizer’s vaccine, Israel’s Health Ministry said on Feb. 20.

New York, New Jersey and Connecticut urged their residents to not travel between the three states as the U.S. Northeast sees a rise in Covid-19 cases, while California said major theme parks including Disneyland would not be opening anytime soon.

Nearly 300,000 more people have died in the United States in 2020 during the coronavirus pandemic than expected based on historical trends, with about two-thirds of the deaths due to Covid-19 illnesses, according to a report.

A roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, the illness caused by the virus.

Join moderator Lynne Devlin, Registered Nurse and VP of Clinical Outreach Services, for a conversation with three people living with cancer about how the threat of COVID-19 is different for them.

With an increased need for the development of vaccines for various illnesses, Pfizer responded with the launch of the company’s Vaccines Division’s Centers of Excellence Network.